We recently published a list of Top 10 AI Stocks Making Headlines Today In this article, we are going to take a look at where ...

BTIG analyst Mark Massaro has initiated coverage on Tempus AI (TEM), with a Buy rating and a price target of $60, implying 48 ...

Tempus AI has reported impressive growth, but some of the volatile quarterly numbers have chased off aggressive investors.

With markets showing signs of life again, some of the most oversold stocks are going along for the ride. That includes ...

BTIG’s Mark Massaro initiated coverage on Tempus AI, Nancy Pelosi's latest stock bet, with a $60 price target that implies a ...

Artificial intelligence (AI) is rapidly being integrated into every domain of healthcare, giving birth to a new class of tech ...

Despite recent volatility, Tempus' AI-driven healthcare strategy and expansion plans draw a bullish call from BTIG ...

Tempus AI reports 30.4% YoY revenue growth in FY2024, driven by genomics and data services. Discover key metrics and ...

As previously reported, BTIG initiated coverage of Tempus AI (TEM) with a Buy rating and $60 price target Tempus AI is a rapidly growing ...

The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas ...

Artificial intelligence (AI) is rapidly being integrated into every domain of healthcare, giving birth to a new class of tech-driven innovators. Tempus AI TEM and Doximity DOCS stand out as ...